Postmarket Drug Safety: The View From the FDA Postmarket Drug Safety: The View From the FDA

Two recent studies have raised potential concerns about the safety of newly approved drugs. What is the FDA ' s safety monitoring process, and are changes needed? Medscape spoke with FDA to find out.FDA Expert Commentaries and Interviews

Source: Medscape Today Headlines - May 19, 2017 Category: Consumer Health News Tags: Pharmacist Expert Interview Source Type: news